Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117156) titled 'SPF of Wellwith SPF-50 Sunscreen' on Sept. 7.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Wellwith India Pvt Ltd.
Intervention:
Intervention1: Test Product: Wellwith SPF 50 Sunscreen: Quantity 2 mg per sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour
Control Intervention1: Not Applicable: Not Applicable
Recruitment Status: Not Recruiting
Phase: Post Marketing Surveillance
Date of First Enrollment: 14-09-2026
Targ...